Analysts at Citi and Bank of America (NYSE:BAC) are maintaining a cautious stance on Hims & Hers Health as competition in the GLP-1 space intensifies and growth begins to moderate.

There's a well-known saying in the investing world, which advises investors to "sell in May and go away." Historically, that ...

Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Former Meta and Time Warner exec Mark D'Arcy is joining Microsoft as a corporate vice president working on the tech ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

Hims & Hers, the telehealth and wellness brand, has announced a surprising and notable hire: Mo Elshenawy, formerly the president and chief technology officer at autonomous vehicle company Cruise, ...

Nader Kabbani, who led the launch of Amazon Pharmacy and the acquisition of PillPack, will take the chief operating officer ...

Hims & Hers Health has named former Amazon executive Nader Kabbani as its new chief operations officer, the health and wellness company announced Monday. Kabbani spent nearly two decades at Amazon and ...